AI Real-World Evidence Analyst
An AI Real-World Evidence Analyst leverages machine learning, natural language processing, and advanced analytics to extract actio…
Skill Guide
The systematic process of identifying and quantifying unintended, systematic errors in clinical AI model outputs that disadvantage specific patient subgroups, and evaluating whether model performance adheres to predefined fairness criteria across protected attributes.
Scenario
You are given a pre-trained model for predicting 30-day hospital readmission and a labeled dataset with demographic columns (age_group, race, gender, insurance_type).
Scenario
A deep learning model for classifying skin lesions performs 15% worse on images of skin tones in Fitzpatrick scale V-VI compared to I-II. The clinical team demands a solution that does not degrade overall performance significantly.
Scenario
Your organization has deployed a model for flagging patients at risk of acute kidney injury (AKI) in the EHR. Leadership requires a system to continuously monitor for fairness drift as patient demographics and clinical practices evolve.
Fairlearn and AIF360 are primary libraries for computing fairness metrics and applying mitigation algorithms. Aequitas provides a audit-focused toolkit. Use MLflow to track fairness metrics alongside model performance over time, and TFDV to detect data drift that could introduce bias.
Use Fairness Trees to choose the right fairness metric based on clinical context. Causal inference (e.g., using DoWhy) helps move beyond correlation to understand if protected attributes cause disparities. Stakeholder Mapping ensures all affected parties (patients, clinicians, insurers) are considered. The Fairness Checklist provides a structured audit workflow.
Answer Strategy
The interviewer is testing your ability to move beyond surface-level metrics and apply a structured diagnostic approach. Use the framework: 1) Data Audit, 2) Metric Deep Dive, 3) Root Cause Analysis, 4) Mitigation, 5) Monitoring. Sample answer: 'First, I'd audit the training data for representation and label quality. Then, I'd compute precision-recall curves and decision thresholds per race. A higher false negative rate suggests the model's decision boundary is less sensitive for this group. The root cause could be biological signal differences or socioeconomic factors correlated with race in the data. I'd then test bias mitigation techniques like equalized odds post-processing or adjusting the decision threshold for the subgroup, while closely monitoring clinical utility metrics like the number needed to screen.'
Answer Strategy
Tests communication and the ability to align technical fairness concepts with business/clinical priorities. Focus on using analogies and focusing on impact. Sample answer: 'I once had to explain why a model achieving demographic parity (equal prediction rates) might not be clinically fair. I used an analogy: a smoke detector that goes off equally often in all rooms regardless of where there's actually smoke isn't fair-it's dangerous. I then presented the alternative: equalizing false negative rates ensures we miss the same proportion of actual high-risk patients in each group. I linked this directly to our goal of reducing preventable adverse events equally across the population, which resonated with their quality improvement mandate.'
1 career found
Try a different search term.